A Single Amino Acid in the M1 Protein Responsible for the Different Pathogenic Potentials of H5N1 Highly Pathogenic Avian Influenza Virus Strains

PLoS One. 2015 Sep 14;10(9):e0137989. doi: 10.1371/journal.pone.0137989. eCollection 2015.

Abstract

Two highly pathogenic avian influenza virus strains, A/duck/Hokkaido/WZ83/2010 (H5N1) (WZ83) and A/duck/Hokkaido/WZ101/2010 (H5N1) (WZ101), which were isolated from wild ducks in Japan, were found to be genetically similar, with only two amino acid differences in their M1 and PB1 proteins at positions 43 and 317, respectively. We found that both WZ83 and WZ101 caused lethal infection in chickens but WZ101 killed them more rapidly than WZ83. Interestingly, ducks experimentally infected with WZ83 showed no or only mild clinical symptoms, whereas WZ101 was highly lethal. We then generated reassortants between these viruses and found that exchange of the M gene segment completely switched the pathogenic phenotype in both chickens and ducks, indicating that the difference in the pathogenicity for these avian species between WZ83 and WZ101 was determined by only a single amino acid in the M1 protein. It was also found that WZ101 showed higher pathogenicity than WZ83 in mice and that WZ83, whose M gene was replaced with that of WZ101, showed higher pathogenicity than wild-type WZ83, although this reassortant virus was not fully pathogenic compared to wild-type WZ101. These results suggest that the amino acid at position 43 of the M1 protein is one of the factors contributing to the pathogenicity of H5N1 highly pathogenic avian influenza viruses in both avian and mammalian hosts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution*
  • Animals
  • Chick Embryo
  • Ducks
  • Influenza A Virus, H5N1 Subtype / genetics*
  • Influenza A Virus, H5N1 Subtype / pathogenicity*
  • Mice
  • Mutation, Missense*
  • Orthomyxoviridae Infections / genetics*
  • Viral Matrix Proteins / genetics*

Substances

  • M1 protein, Influenza A virus
  • Viral Matrix Proteins

Grants and funding

This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) (http://www.amed.go.jp/en/), KAKENHI (https://www.jsps.go.jp/english/index.html), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (http://www.mext.go.jp/english/), and partly by the Japan Science and Technology Agency (JST) (http://www.jst.go.jp/EN/index.html) and Japan International Cooperation Agency (JICA) (http://www.jica.go.jp/english/index.html) within the framework of the Science and Technology Research Partnership for Sustainable Development (SATREPS) (http://www.jst.go.jp/global/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.